Pivotal Scientific advises Antibody BCN on its sale to CliniSciences

Jake Bernard

Jun 15, 2020

Exit Strategy 3

CliniSciences adds to its portfolio of companies

Pivotal Scientific Limited (PSL) is pleased to announce its assistance in the sale of Spanish based Biotechnology company AbBcn S.L. (AntibodyBCN) to the French distribution company CliniSciences. The acquisition will broaden CliniSciences product portfolio for customised production of antibodies and distribution.

AbBcn S.L. approached PSL for assistance in finding potential buyers. PSL used its extensive database and expert knowledge of the global biotech landscape, approached companies looking to buy and facilitated this introduction.

“Companies are reaching out to us regularly when looking to Merge, Acquire or wanting to investigate management buyouts. AbBcn S.L. reached out and we were able to find a suitable buyer very quickly for them. A great addition to CliniSciences portfolio”

Tim Bernard, CEO, Pivotal Scientific Limited

If you are looking to buy or sell a company, visit PSL`s Mergers & Acquisitions page or contact us to find out how we can guide you through the process.